XML 41 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Awards (Tables)
3 Months Ended
Mar. 31, 2020
Stock-Based Awards  
Assumptions used to determine fair value of stock options granted

 

 

 

 

 

 

 

 

 

    

Three Months Ended

 

 

 

 

March 31, 

 

 

 

 

2020

 

 

2019

 

 

Risk-free interest rate

 

0.97

%

 

2.53

%

 

Expected term (in years)

 

6.2

 

 

6.3

 

 

Expected volatility

 

85.28

%

 

101.70

%

 

Expected dividend yield

 

 0

%

 

 0

%

 

 

Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted

    

 

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

 

 

 

Average

 

Remaining

 

Aggregate

 

 

 

Number

 

Exercise

 

Contractual

 

Intrinsic

 

 

 

of Shares

 

Price

 

Term

 

Value

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Outstanding as of December 31, 2019

 

3,102,221

 

$

20.33

 

6.55

 

$

148

 

Granted

 

602,800

 

 

1.28

 

 

 

 

 

 

Exercised

 

 —

 

 

 —

 

 

 

 

 

 

Forfeited and cancelled

 

(275,088)

 

 

21.36

 

 

 

 

 

 

Outstanding as of March 31, 2020

 

3,429,933

 

$

16.90

 

6.70

 

$

21

 

Options vested and expected to vest as of March 31, 2020

 

3,429,933

 

$

16.90

 

6.70

 

$

21

 

Options exercisable as of March 31, 2020

 

2,121,161

(1)

$

19.47

 

5.46

 

$

21

 


(1)

All options granted under the 2012 Plan are exercisable immediately, subject to a repurchase right in the Company’s favor that lapses as the option vests. This amount reflects the number of shares under options that were vested, as opposed to exercisable, as of March 31, 2020. 

Summary of restricted stock units activity

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

 

 

 

Number

 

Fair Value

 

 

 

of Shares

 

Per Share

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2019

 

3,592,915

 

$

4.62

 

Granted

 

977,385

 

 

1.26

 

Vested

 

(430,896)

 

 

6.62

 

Forfeited and cancelled

 

(269,345)

 

 

4.96

 

Outstanding as of March 31, 2020

 

3,870,059

 

$

3.52

 

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

     

2020

     

2019

 

Cost of revenue

  

$

260

    

$

206

 

Research and development

 

 

816

 

 

1,594

 

General and administrative

 

 

2,377

 

 

2,472

 

Total stock-based compensation expense

 

$

3,453

 

$

4,272